Average Co-Inventor Count = 3.81
ph-index = 2
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Xenoport, Inc. (9 from 142 patents)
2. Genentech, Inc. (2 from 3,221 patents)
3. Arbor Pharmaceuticals, LLC (2 from 20 patents)
13 patents:
1. 11365197 - Dosage form compositions comprising an inhibitor of Bruton's tyrosine kinase
2. 10940117 - Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof
3. 10716760 - Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof
4. 10246461 - Dosage form compositions comprising an inhibitor of bruton's tyrosine kinase
5. 9895336 - Crystalline forms of (N, N-Diethylcarbamoyl)methyl methyl (2E)but-2-ene-1,4-dioate, methods of synthesis and use
6. 9795581 - Crystalline forms of (N,N-Diethylcarbamoyl)methyl methyl (2E)but-2-ene-1,4-dioate, methods of synthesis and use
7. 9682057 - Crystalline forms of (N,N-Diethylcarbamoyl)methyl methyl (2E)but-2-ene-1,4-dioate, methods of synthesis and use
8. 9597292 - Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof
9. 9421182 - Cocrystals of dimethyl fumarate
10. 9416096 - Crystalline forms of (N,N-Diethylcarbamoyl)methyl methyl (2E)but-2-ene-1,4-dioate, methods of synthesis and use
11. 8722733 - Levodopa prodrug mesylate hydrate
12. 8435562 - Pharmaceutical compositions and oral dosage forms of a levodopa prodrug and methods of use
13. 8399513 - Levodopa prodrug mesylate hydrate